Cefpodoxime Proxetil and Potassium Clavulanate Tablets
Product Name: Cefpodoxime Proxetil and Potassium Clavulanate Tablets
Common Name: Cefpodoxime with Clavulanic Acid
Strength: 200 mg + 125mg per tablet
Description:
Cefpodoxime Proxetil and Potassium Clavulanate Tablets combine the broad-spectrum antibiotic cefpodoxime, a third-generation cephalosporin, with potassium clavulanate, a beta-lactamase inhibitor. Cefpodoxime works by inhibiting bacterial cell wall synthesis, effectively treating a wide range of bacterial infections. Potassium clavulanate protects cefpodoxime from degradation by beta-lactamase enzymes produced by resistant bacteria, enhancing its efficacy.
This combination is particularly useful in overcoming antibiotic resistance and is used to treat infections caused by susceptible strains of bacteria.
Indication and Usage:
Cefpodoxime Proxetil and Potassium Clavulanate Tablets are indicated for the treatment of bacterial infections, including:
- Respiratory tract infections (bronchitis, pneumonia)
- Urinary tract infections (UTIs)
- Skin and soft tissue infections
- Ear, nose, and throat infections (sinusitis, tonsillitis)
- Gonococcal infections
This combination is highly effective in treating infections caused by beta-lactamase-producing bacteria. The tablets should be taken as prescribed by a healthcare provider, with or without food, and the duration of treatment varies based on the infection being treated.
Features:
- Broad-spectrum antibiotic for resistant bacterial infections.
- Combines cefpodoxime with clavulanate for enhanced activity.
- Effective against a wide range of respiratory, urinary, and skin infections.
Pack Size: Cefpodoxime Proxetil and Potassium Clavulanate Tablets has 60 tablets in each pack. It can be customise as per buyer’s specification.
Minimum Order Quantity: 3500 Packs
Certification: WHO-GMP Certified Facility.
